2013
DOI: 10.1016/j.ajog.2012.10.877
|View full text |Cite
|
Sign up to set email alerts
|

Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis

Abstract: OBJECTIVE No randomized controlled trial has directly compared vaginal progesterone and cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix in the midtrimester, singleton gestation, and previous spontaneous preterm birth. We performed an indirect comparison of vaginal progesterone versus cerclage, using placebo/no cerclage as the common comparator. STUDY DESIGN Adjusted indirect meta-analysis of randomized controlled trials. RESULTS Four studies evaluating vaginal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
92
0
9

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 138 publications
(105 citation statements)
references
References 221 publications
4
92
0
9
Order By: Relevance
“…There are relatively few mouse models that have demonstrated a preterm birth phenotype, and these mouse models include the following: lipopolysaccharide inflammatory response (83), acute alcohol exposure in late pregnancy (84), progesterone-receptor antagonism (85), Stat5b knockout mice (86,87), inactivation of cannabinoid receptor CB1 (88), and Trp53 deletion in progesterone receptor expressing cell linages (89). A unique distinction of our model is that the gestation length was rescued by exogenous progesterone administration, the only proven clinical treatment for women with a history of preterm birth (90)(91)(92). Progesterone production in humans is different in that the syncytiotrophoblast of the placenta is the progesterone producing cells after the first 8 wk of gestation (93).…”
Section: Discussionmentioning
confidence: 99%
“…There are relatively few mouse models that have demonstrated a preterm birth phenotype, and these mouse models include the following: lipopolysaccharide inflammatory response (83), acute alcohol exposure in late pregnancy (84), progesterone-receptor antagonism (85), Stat5b knockout mice (86,87), inactivation of cannabinoid receptor CB1 (88), and Trp53 deletion in progesterone receptor expressing cell linages (89). A unique distinction of our model is that the gestation length was rescued by exogenous progesterone administration, the only proven clinical treatment for women with a history of preterm birth (90)(91)(92). Progesterone production in humans is different in that the syncytiotrophoblast of the placenta is the progesterone producing cells after the first 8 wk of gestation (93).…”
Section: Discussionmentioning
confidence: 99%
“…One review did an indirect comparison meta-analysis of vaginal progesterone and cerclage, 65 but did not combine the direct and indirect estimates or assess the probability of each intervention being the best. Our findings of reductions in PTB < 34 and <37 weeks and NND with progesterone are consistent with the previous individual systematic review on progesterone, although our findings on cerclage, with the inclusion of additional studies, differed from the previous meta-analysis, which included unpublished data 4 and in which a significant effect of cerclage in preventing PTB < 34, <37 and <28 weeks was found.…”
Section: Interpretation In Light Of Other Evidencementioning
confidence: 99%
“…Both interventions were associated with a statistically significant reduction in the risk of preterm birth <32 weeks of gestation and composite perinatal morbidity and mortality compared with placebo/no cerclage. Adjusted indirect meta-analyses did not show statistically significant differences between vaginal progesterone and cerclage in reducing preterm birth or adverse perinatal outcomes 41 .…”
Section: Discussion:-mentioning
confidence: 99%